Reagenics Research News
9 articles
Margot Stern - The Future of Protein Production
The article discusses the importance of privacy and data storage when visiting websites. It explains that websites may store or retrieve data in your browser for basic functionality, marketing, analytics, and personalization purposes. The data stored can be used to deliver relevant advertising, remember user preferences, and understand how the website performs and how visitors interact with it. The article emphasizes the importance of privacy and gives users the option to disable certain types of storage that may not be necessary for the basic functioning of the website.
Not applicable
ReaGenics cracks code to produce 'commercially viable' quantities of cannabinoids, other bioactives via plant cell culture
Israeli startup ReaGenics has developed a novel method to produce commercially viable quantities of a broad spectrum of cannabinoids from cannabis plant cells. The company has also developed plant cell culture techniques to grow everything from saffron to coffee, peyote, resveratrol, and anthocyanins from purple maize. ReaGenics is in talks with an international conglomerate about partnering and another international company with an interest in plant proteins. The company recently partnered with a Colorado company that manufactures cannabinoid oils. ReaGenics has raised $3.3 million in seed funding and is now raising a $6 million low A round.
InvestmentPartners
Up the Ladder: ReaGenics Promotes Jonny Cline to Chief Operations Officer
ReaGenics, a plant molecular harvesting company, has promoted Jonny Cline to Chief Operations Officer (COO). Cline previously served as the companys operations and human resources executive vice president. He has extensive experience in senior roles in the start-up arena and in organizations in the social sector. ReaGenics recently announced a partnership with KND Labs, a leading manufacturer of nutraceutical ingredients, to enable KND to expand its product offerings in the global nutraceutical and ingredients marketplace.
Management ChangesPartners
Reagenics: Plant molecular harvesting in Israel
Reagenics plant cells in bioreactors. The cells can be used for food products, dyes, vitamins and food additives.
Reagenics, an Israeli company, is addressing the global food shortage by growing plant cells in bioreactors. These cells can be used for food products, dyes, vitamins, and food additives. Unlike traditional agriculture, bioreactors are not dependent on weather conditions, available land, or political unrest. The company has already scaled up by building bioreactors in Nes Ziona and a pilot plant in the Golan Heights, with plans to build a bioreactor in Denver, Colorado. Reagenics can grow plant cells four times faster than traditional agriculture and at a lower cost. The company is also working on other uses like cosmetics and food additives.
Expand
KND Labs and ReaGenics Announce Partnership to Expand Business Lines
KND Labs, a manufacturer of nutraceutical ingredients, has announced a partnership with Israel-based plant molecular harvesting company ReaGenics. The partnership will allow KND Labs to expand its product offerings in the global nutraceutical and ingredients marketplace. KND Labs currently serves many industries and is an ingredient partner to many of the world’s largest product brands. The ReaGenics partnership will enable KND Labs to apply its knowledge of scaled production to new ingredients. ReaGenics provides technology to support the growth of living plant stem cells economically and at scale.
PartnersExpand
Israeli startup growing plant cells for pharma, in the lab
ReaGenics, an Israeli startup, is leading the way in lab-grown plant cells for industrial scale, pharma-grade production. The company uses novel cell bioreactors to culture botanical molecules, a process that doesnt require large amounts of land and resources. The process starts with differentiated cells taken from a living plant, which are then decontaminated and placed in petri dishes. Instead of regenerating into a new plant, the cells are forced to revert to stem cells.
Expand
Growing plant cells for pharma in the lab: "Cannabis is challenging"
Israeli startup ReaGenics is leading the way in lab-grown plant technology, with a particular focus on cannabis and psilocybin. The company, which started in 2019, aims to treat inflammatory bowel disease with cannabis. However, achieving a consistent formulation of cannabinoids when the plants are grown outdoors or indoors is challenging. ReaGenics can generate the precise molecules needed to ensure cannabis consistency, which is crucial for the entourage effect.
CustomersExpand
Growing plant cells for pharma, in the lab - ISRAEL21c
Israeli startup ReaGenics is pioneering the cultivation of plant molecules in a lab, a process that could help mitigate the effects of climate change on crops and enable easier production of plants with medicinal properties. The company uses bioreactors to grow stem cells from plants, which can then be harvested for their molecules. The process could be used to produce a variety of products, from affordable saffron to consistent formulations of cannabinoids for medical use. ReaGenics has raised $3.3 million in funding and plans to build a production facility in Israel with up to 200 bioreactors.
InvestmentExpand
Israel Wants To Be The Capital Of Medical Cannabis
The iCanConnect Symposium, a pitch-day for Israeli and Israel-adjacent cannabis entrepreneurs, was held in midtown Manhattan. The event was run by CannaTech, a group that organizes international conferences for cannabis merchants. The symposium was attended by a number of startups seeking funding for cannabis-based businesses. Notably, the Israeli government is working on branding weed products and partnering internationally with regulators like the FDA to prepare for Israeli cannabis products to be exported. The event also highlighted the potential of cannabis for the Israeli economy and the need to overcome stigma and ignorance around cannabis.
InvestmentExpand